Apoptosis-Inducing and Proliferation-Inhibiting Effects of Doramectin on Mz-ChA-1 Human Cholangiocarcinoma Cells
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252413440 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yunfang Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen 361102, China. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Cell Proliferation, Apoptosis, Ivermectin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Xiamen Southern Oceanographic Center, Technology Innovation Center for Exploitation of Marine Biological Resources, MNR.
Abstract (Originalsprache)
Cholangiocarcinoma is a malignant tumor that emerges in the intrahepatic or extrahepatic bile ducts. Doramectin (DOR), a third-generation derivative of avermectins (AVMs), is renowned for its low toxicity and high efficiency. However, no research has hitherto focused on the anti-cholangiocarcinoma effects of these drugs. In this study, we undertook a preliminary exploration of the mechanism through which DOR inhibits the viability of human cholangiocarcinoma cells (Mz-ChA-1) via transcriptome analysis and molecular validation at the cellular level. The results indicated that DOR could suppress the growth and proliferation of Mz-ChA-1 cells in a dose-dependent manner. Moreover, it significantly diminished their migration and invasion abilities. Cell cycle analysis disclosed arrest in the G1 phase, accompanied by an increase in p21 expression and a decrease in the levels of the cyclin E1 and CDK2 proteins. Additionally, DOR induced apoptosis via the ROS-triggered mitochondrial pathway. This was attested by an elevation in the BAX/BCL-2 ratio, the activation of caspase 3/7 and the cleavage of PARP1. These mechanistic insights underscore DOR’s potential as a therapeutic agent against cholangiocarcinoma
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen 361102, China.
- Key Laboratory of Marine Genetic Resources, Third Institute of Oceanography, Ministry of Natural Resources, Xiamen 361005, China.
- Co-Innovation Center of Jiangsu Marine Bio-Industry Technology, Jiangsu Ocean University, Lianyungang 222000, China.
ORCID-Profile: Wei Wu, Yan Shi, Mingliang Chen, Qin Wang
Förderung
- National Natural Science Foundation of China
- Xiamen Southern Oceanographic Center
- Technology Innovation Center for Exploitation of Marine Biological Resources, MNR
- the Beihai Pilot City Program for the National Innovative Development of the Marine Economy
- Beihai Pilot City Program for the National Innovative Development of the Marine Economy
Zitieren
APA
Zhang, Y., Wu, W., Shi, Y., Huang, Y., Dai, T., Ke, L., Chen, L., Chen, M., & Wang, Q. (2024). Apoptosis-Inducing and Proliferation-Inhibiting Effects of Doramectin on Mz-ChA-1 Human Cholangiocarcinoma Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252413440
Vancouver
Zhang Y, Wu W, Shi Y, Huang Y, Dai T, Ke L, et al. Apoptosis-Inducing and Proliferation-Inhibiting Effects of Doramectin on Mz-ChA-1 Human Cholangiocarcinoma Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252413440
BibTeX
@article{Zhang2024,
author = {Zhang, Yunfang and Wu, Wei and Shi, Yan and Huang, Yuehong and Dai, Ting and Ke, Lina and Chen, Lizhu and Chen, Mingliang and Wang, Qin},
title = {Apoptosis-Inducing and Proliferation-Inhibiting Effects of Doramectin on Mz-ChA-1 Human Cholangiocarcinoma Cells},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252413440}
}
EUVIMED